000 01533 a2200385 4500
005 20250516233055.0
264 0 _c20151215
008 201512s 0 0 eng d
022 _a1523-4681
024 7 _a10.1002/jbmr.2361
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEastell, Richard
245 0 0 _aRelationship between pretreatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension study.
_h[electronic resource]
260 _bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
_cMar 2015
300 _a570-4 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aBone Density
650 0 4 _aBone Density Conservation Agents
_xtherapeutic use
650 0 4 _aDiphosphonates
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImidazoles
_xtherapeutic use
650 0 4 _aOsteoporosis
_xdrug therapy
650 0 4 _aPlacebos
650 0 4 _aZoledronic Acid
700 1 _aBoonen, Steven
700 1 _aCosman, Felicia
700 1 _aReid, Ian R
700 1 _aPalermo, Lisa
700 1 _aCummings, Steven R
700 1 _aBlack, Dennis M
773 0 _tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
_gvol. 30
_gno. 3
_gp. 570-4
856 4 0 _uhttps://doi.org/10.1002/jbmr.2361
_zAvailable from publisher's website
999 _c24183867
_d24183867